Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: TheBusDriver who wrote (11918)	1/22/2003 2:59:11 AM
From: axial	Read Replies (1) \| Respond to of 14101

Wayne, in a bear market there's bound to be a selloff when news hits. Lots of people running for cover, these days. CC is right to be cautious. The story will be told after the Pennsaid news passes, and the product starts to move. Most Canadians live within 100 miles of the US border. When we start to see signs of the US marketing campaign, when the market gets a feel for what's developing - that's when things will settle down. Pennsaid's not Viagra. It's not going to explode into the market. The thing is, the stuff really works! You know it, and I know it. Sooner or later, the Maureens (the UK arthritis poster) of this world will put the word out, and Pennsaid will finally be available for people who need it - and, in demand. A long string of delays and disappointments has dampened enthusiasm, but this is the fact: in certain applications, there's nothing better than Pennsaid. I believe the product is a winner. Regards, Jim